NL-OMON40904已完成不适用
A single-center, open-label study to investigate the absorption, distribution, metabolism and excretion (ADME) of LEE011 after a single oral dose of 600 mg [14C]LEE011 (0.37 MBq) in healthy male subjects - Human metabolism and mass balance study of LEE011
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- ovartis
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •healthy male subjects
- •45 - 65 yrs, inclusive
- •BMI: 18.0 - 30.0 kg/m2, inclusive
- •non-smoking
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 0.4 liters of blood in the 8 weeks prior the start of this study.
研究者
相似试验
已完成
不适用
A single-center, open-label study to investigate the absorption, distribution, metabolism and excretion (ADME) of HDM201 (Siremadlin) after a single oral dose of 25 mg [14C]HDM201 in healthy subjects10027656CancerNL-OMON49451ovartis Pharma AG5
已完成
不适用
A single-center, open-label study to investigate the mass balance, excretion pathways, and metabolites after a single oral dose of 500 mg, 3.7 MBq, [14C]BTZ-043 in healthy male volunteersTuberculosisNL-OMON50849niversity Hospital LMU Klinikum4
已完成
不适用
A single-center, open-label study to investigate the absorption, distribution, metabolism and excretion (ADME) of INC280 after a single oral dose of 600 mg [14C] INC280 (5.55 MBq) in healthy male subjectscancerNL-OMON41012ovartis6
已完成
4 期
To evaluate the efficacy of a cosmetic/ayurvedic formulation in the treatment of Miliaria (Prickly Heat)CTRI/2013/07/003822CHOLAYIL PVT LTD35
已完成
不适用
An open-label, single center study to determine the absorption, distribution, metabolism, and excretion (ADME) of a single oral dose of [14C]LDE225 (74 kBq) to healthy male subjectskwaadaardige tumorenmalignant tumorsNL-OMON37376ovartis6